The vaccine maker has been seeking a new manufacturing partner since U.S. authorities decided that Emergent BioSolutions could not produce its coronavirus vaccine.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register. By continuing to use this site, you are consenting to our use of cookies.